PT UBC Medical Indonesia Tbk (IDX:LABS)

Market Cap	485.85B
Revenue (ttm)	147.64B
Net Income (ttm)	2.95B
Shares Out	3.95B
EPS (ttm)	0.75
PE Ratio	164.57
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	730,500
Average Volume	798,210
Open	124.00
Previous Close	123.00
Day's Range	121.00 - 124.00
52-Week Range	107.00 - 228.00
Beta	n/a
RSI	70.68
Earnings Date	Apr 30, 2025

About IDX:LABS

PT UBC Medical Indonesia Tbk distributes medical devices in Indonesia. It operates in two segments, Medical Disposables and Consumables, and Diagnostics and Equipment. The company offers next generation molecular, retina AI, infectious disease, HPV DNA test, real time PCR, TB management, and newborn screening products. PT UBC Medical Indonesia Tbk was founded in 2014 and is based in Jakarta Timur, Jakarta. PT UBC Medical Indonesia Tbk operates as a subsidiary of PT Optel Investama Mulia.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2014
• Employees: 62
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: LABS

Financial Performance

In 2024, IDX:LABS's revenue was 147.64 billion, an increase of 8.00% compared to the previous year's 136.70 billion. Earnings were 2.95 billion, an increase of 34.84%.